Cargando…

Editorial: Fibrosis: etiology, pathophysiology, measurements, and therapy

Detalles Bibliográficos
Autores principales:	Liu, Yanping, Xu, Jiupan, Zhao, Yuxia, Hao, Panpan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227568/ https://www.ncbi.nlm.nih.gov/pubmed/37261281 http://dx.doi.org/10.3389/fphar.2023.1201830

Ejemplares similares

Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention
por: Yin, Xiaoying, et al.
Publicado: (2023)

Animal Models in the Pathophysiology of Cystic Fibrosis
por: Semaniakou, Anna, et al.
Publicado: (2019)

The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies
por: Xu, Jun, et al.
Publicado: (2014)

Editorial: Eye Pain: Etiology and Therapeutic Approaches
por: Rusciano, Dario, et al.
Publicado: (2022)

Gene therapy for cystic fibrosis: Challenges and prospects
por: Sui, Hongshu, et al.
Publicado: (2022)

Editorial: The Cell Types of Fibrosis
por: Murray, Lynne A.
Publicado: (2016)

Editorial: Relevance of Steroid Biosynthesis, Metabolism and Transport in Pathophysiology and Drug Discovery
por: Rižner, Tea Lanišnik
Publicado: (2019)

Effectiveness and safety of four different beta‐blockers in patients with chronic heart failure
por: Liu, Baoshan, et al.
Publicado: (2023)

ADAM17 knockdown mitigates while ADAM17 overexpression aggravates cardiac fibrosis and dysfunction via regulating ACE2 shedding and myofibroblast transformation
por: Cheng, Jing, et al.
Publicado: (2022)

Editorial: Applications of medicine in treating pulmonary fibrosis
por: Li, Wenjun, et al.
Publicado: (2023)

Editorial: Emerging Therapeutic Approaches for Cystic Fibrosis
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2019)

Editorial: Premature Aging and Senescence in Renal Fibrosis
por: Samarakoon, Rohan, et al.
Publicado: (2021)

Editorial: Fibrosis and Inflammation in Tissue Pathophysiology
por: Chimenti, Isotta, et al.
Publicado: (2022)

Editorial: New Insights Into Renal Fibrosis and Therapeutic Effects of Natural Products
por: Xu, Ying, et al.
Publicado: (2022)

Editorial: Investigating the molecular targets and therapeutic potential of Withania somnifera (Ashwagandha) in various pathophysiological conditions
por: Dar, Nawab John, et al.
Publicado: (2023)

Editorial: Novel Therapeutic Targets and Emerging Treatments for Fibrosis
por: Samuel, Chrishan S., et al.
Publicado: (2017)

Editorial: Pulmonary fibrosis: One manifestation, various diseases
por: Ruaro, Barbara, et al.
Publicado: (2022)

Editorial: Pathophysiological and clinical advances in asthmatic inflammation from the nasopharynx to the peripheral airway in the respiratory tract systems
por: Koga, Yasuhiko, et al.
Publicado: (2023)

Editorial: New insights into pathophysiology and management of pregnancy in systemic autoimmune diseases: Toward new therapeutic approaches
por: Bettiol, Alessandra, et al.
Publicado: (2022)

Editorial: Inflammation and Fibrosis in the Gastrointestinal Tract and Liver: Mechanisms and Targets
por: Weiskirchen, Ralf, et al.
Publicado: (2021)

Editorial: Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
por: Ribeiro, Carla Maria Pedrosa, et al.
Publicado: (2021)

Editorial: New Approaches to Tackle EMT and Fibrosis: From Epigenetics to Nanotechnology
por: Battistelli, Cecilia, et al.
Publicado: (2021)

Pathophysiology of the Belgrade rat
por: Veuthey, Tania, et al.
Publicado: (2014)

Editorial: Mitochondrial therapy in neurodegeneration
por: Kalani, Anuradha, et al.
Publicado: (2023)

Editorial: Microbiome in IBD: From Composition to Therapy
por: Zhu, Ruixin, et al.
Publicado: (2021)

Editorial: Molecular Mechanisms and New Therapeutic Targets in Epithelial to Mesenchymal Transition (EMT) and Fibrosis
por: Battistelli, Cecilia, et al.
Publicado: (2020)

Editorial: New insights into renal fibrosis and therapeutic effects of natural products volume II
por: Chen, Dan-Qian, et al.
Publicado: (2022)

Editorial: Adaptive immune resistance in cancer therapy
por: Jiang, Aimin, et al.
Publicado: (2023)

Hypoglycemic medicines in the treatment of Alzheimer’s disease: Pathophysiological links between AD and glucose metabolism
por: Wang, Yixuan, et al.
Publicado: (2023)

Cell-Based Therapies for Tissue Fibrosis
por: Lim, Rebecca, et al.
Publicado: (2017)

The importance of iron in pathophysiologic conditions
por: Gozzelino, Raffaella, et al.
Publicado: (2015)

Editorial: Novel biomarkers for anticancer therapy
por: Wang, Ting, et al.
Publicado: (2023)

Editorial: New Therapies in the Field of Rheumatology
por: Chighizola, Cecilia Beatrice, et al.
Publicado: (2020)

The Leukemias. Etiology, Pathophysiology, and Treatment
por: Detre, Katherine D.
Publicado: (1958)

Exacerbations: Etiology and Pathophysiologic Mechanisms
por: Wedzicha, Jadwiga A.
Publicado: (2002)

Editorial: “Ion channels and mental illness: exploring etiology and pathophysiology in major psychiatric disorders”
por: Askland, Kathleen D.
Publicado: (2015)

Editorial: Human microbiota: A key player in the etiology and pathophysiology of cardiovascular and metabolic diseases
por: Velmurugan, Ganesan, et al.
Publicado: (2022)

Editorial: Microbiome in IBD: From Composition to Therapy, Volume II
por: Liu, Ning-Ning, et al.
Publicado: (2023)

Editorial: Molecular mechanisms and new therapeutic targets in epithelial to mesenchymal transition (EMT) and fibrosis, volume II
por: Battistelli, Cecilia, et al.
Publicado: (2022)

Comparison on different traditional Chinese medicine therapies for chronic hepatitis B liver fibrosis
por: Dai, Yun-kai, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8k8ust5rnmd3c8578a9vdfrsbo